Ronald Blue Trust, Inc. Compugen LTD Transaction History

Ronald Blue Trust, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$1.41 - $1.93 $63 - $86	-45 Reduced 0.79%	5,618 $8,000
Q3 2024 Oct 17, 2024	BUY	$1.56 - $2.1 $3,173 - $4,271	2,034 Added 56.05%	5,663 $10,000
Q2 2024 Jul 18, 2024	BUY	$1.68 - $2.52 $6,096 - $9,145	3,629 New	3,629 $6,000
Q4 2023 Jan 18, 2024	BUY	$0.53 - $2.0 $1,923 - $7,258	3,629 New	3,629 $3,000
Q4 2022 Jan 17, 2023	BUY	$0.58 - $1.2 $80 - $166	139 New	139 $0

12M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $200M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.